Skip to content

PLRZ

Polyrizon Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$9.69
−3.15%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue306.0K342.0K118.0K4.0K5.0K
Gross Profit(306.0K)(342.0K)(118.0K)(4.0K)(5.0K)
Operating Expenses
R&D Expense4.1M2.1M534.0K332.0K347.0K
SG&A Expense7.7M3.8M768.0K303.0K548.0K
General & Admin Expense2.7M—768.0K303.0K533.0K
Selling & Marketing Expense————15.0K
Other Expenses—————
Total Operating Expenses11.8M5.9M1.3M635.0K895.0K
Cost and Expenses12.7M6.2M1.3M635.0K895.0K
Operating Income (EBIT)(12.7M)(6.2M)(1.3M)(635.0K)(895.0K)
Non-Operating
Interest Income2.3M370.0K———
Interest Expense7.0K3.1M3.0K2.0K2.0K
Net Interest Income2.4M(2.8M)(28.0K)(230.0K)(2.0K)
Other Non-Op Income/Expense7.3M2.9M(243.0K)35.0K116.0K
Non-Operating Income (excl Interest)——240.0K(37.0K)(118.0K)
EBT (Pre-Tax Income)(5.5M)(3.3M)(1.5M)(600.0K)(779.0K)
Income Tax Expense—————
Bottom Line
Net Income(5.5M)(3.3M)(1.5M)(600.0K)(779.0K)
Earnings from Cont. Ops(5.5M)(3.3M)(1.5M)(600.0K)(779.0K)
Earnings from Discont. Ops—————
Bottom Line Net Income(6.9M)(3.3M)(1.6M)(669.0K)(823.0K)
Per Share
Basic EPS($4.55)($2.07)($134.14)$0.00$0.00
Diluted EPS($4.55)($2.07)($134.14)$0.00$0.00
Revenue Per Share$0.00$0.00$0.00$0.00—
Shares
Basic Shares Outstanding1.8M1.6M110002796—
Diluted Shares Outstanding1.8M1.6M119652796—
Profitability Metrics
EBITDA(12.3M)(5.9M)(1.4M)(631.0K)(772.0K)
D&A459.0K342.0K118.0K4.0K5.0K
EBIT(12.7M)(6.2M)(1.5M)(635.0K)(777.0K)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026